Sequential vaccination with heterologous HA elicit more uniformed T-cell responses. Sequential vaccination with heterologous HA elicit more broader cross-reactive nAb. Broad monoclonal nAb could be isolated form sequential vaccinated mice. An universal vaccine is possible by employ the sequential vaccination strategy.